Most taiwan ms orphan disease related news are at:
guthyjacksonfoundation.org
– The Guthy-Jackson Charitable Foundation - Learn About NMO
Alexion’s Soliris(R) (eculizumab) Receives Orphan Drug Designation for the Treatment of Neuromyelitis Optica (NMO) 2 Jul 2013 | 02:31 am
CHESHIRE, Conn., Jun 27, 2013 (BUSINESS WIRE) — Alexion Pharmaceuticals, Inc. ALXN today announced that Soliris(R) (eculizumab), the company’s first-in-class terminal complement inhibitor, has been gr...
Journal Watch: Soliris For Treating Neuromyelitis Optica 6 Jun 2013 | 08:29 pm
Possible good news for patients with neuromyelitis optica (aka Devic’s syndrome) and for stock holders of Alexion Pharmaceuticals. The drug Soliris (eculizumab) may be a safe and effective treatment ...
